| 1.0 |
2.9 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.9 |
2.8 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.8 |
0.8 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.6 |
1.9 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.6 |
2.9 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 |
2.7 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.5 |
1.6 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.5 |
1.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.5 |
1.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.5 |
3.5 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 |
1.7 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.4 |
0.8 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.3 |
1.0 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.3 |
1.0 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 |
1.5 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.3 |
2.8 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
0.8 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
0.8 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) regulation of heart induction(GO:0090381) negative regulation of dopaminergic neuron differentiation(GO:1904339) regulation of cardiac cell fate specification(GO:2000043) |
| 0.2 |
0.9 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.2 |
0.7 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.2 |
0.6 |
GO:0015920 |
regulation of phosphatidylcholine catabolic process(GO:0010899) lipopolysaccharide transport(GO:0015920) |
| 0.2 |
0.8 |
GO:0097168 |
condensed mesenchymal cell proliferation(GO:0072137) mesenchymal stem cell proliferation(GO:0097168) |
| 0.2 |
0.7 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
0.5 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.2 |
0.9 |
GO:0002317 |
plasma cell differentiation(GO:0002317) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.3 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.1 |
0.4 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.1 |
0.9 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.6 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
2.6 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.6 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
1.7 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
1.7 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.8 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.4 |
GO:0061428 |
positive regulation of oocyte development(GO:0060282) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
1.1 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
0.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.2 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 |
0.3 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
0.3 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.6 |
GO:0031424 |
keratinization(GO:0031424) establishment of skin barrier(GO:0061436) |
| 0.1 |
0.7 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
1.3 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.2 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.1 |
0.5 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.1 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.3 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.4 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.0 |
0.4 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.3 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
1.5 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.2 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.0 |
1.0 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 |
0.5 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 |
0.9 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.0 |
0.2 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
3.8 |
GO:0046330 |
positive regulation of JNK cascade(GO:0046330) |
| 0.0 |
0.1 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.2 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.0 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.5 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.0 |
0.0 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.0 |
0.3 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
1.3 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) |
| 0.0 |
0.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
1.7 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.4 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
